When Deanna Hogue needed a doctor on a holiday weekend, she reached her physician on his cell phone. Dr. James Gardner III immediately responded. Hogue and her husband, Chad, are among nearly 400 ...

The Wilmington lab is expected to be functional by 2028. "The Merck Wilmington Biotech site represents our continued commitment to growing our investments in U.S. manufacturing and has the ...

Incyte's stock valuation is on the higher side given looming patent expiries for Jakafi and Opzelura, and uncertain pipeline ...

The new Merck complex in Wilmington will be a “cornerstone of our biotech future,” chief executive Robert M. Davis said at a groundbreaking Tuesday on the former DuPont Co. chemical and office ...

The Greater Wilmington Chamber of Commerce has announced the recipients of the 2025 40 Under 40 Awards. The honor recognizes ...

Merck’s Keytruda, with more than 40 approved indications, hasn’t yet been able to crack specifically into ovarian cancer. But with promising early results from a phase 3 study in certain ...

Merck will have early-stage opportunities to help startups set up for future success in the pharmaceutical and life sciences fields. Merck KGaA (Merck), headquartered in Darmstadt, Germany, and Israel ...

As has been the case for several quarters now, Merck KGaA’s life science business continues to serve as a weathervane for the broader biopharma industry. For the full year, Merck now expects ...

SHANGHAI, May 14 (Reuters) - German healthcare and materials group Merck KGaA (MRCG.DE), opens new tab has dropped a surcharge on life sciences sector orders within China following the U.S.-China ...

RAHWAY, N.J. – Merck & Co., Inc., a global healthcare leader, announced positive results from its Phase 3 KEYNOTE-B96 trial, which could potentially lead to a new treatment option for patients ...